Compare Edwards Lifesciences Corporation Common Stock (EW) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs PAGSEG Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while PAGSEG Inc trades at $10.65 (market cap $2.90B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 17× PAGSEG Inc's market cap, and PAGSEG Inc pays a 10.66% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | PAGS | |
|---|---|---|
Market Cap | $49.44B | $2.90B |
Volume | 3,508,027 | 4,931,855 |
Sector | Health | Industrials |
52-Week High | $95.18 | $12.00 |
52-Week Low | $72.65 | $8.44 |
Enterprise Value | $45.90B | $11.04B |
Typical Hold Time | — | 26 Days |
Dividend Yield | — | 10.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PAGS trades at $10.51, down 1.96% on the day, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 7 and net income margin of 10.45%, supported by recent earnings beats. A dividend of $0.28 is scheduled for September 2026. Analyst consensus is bullish with a $10.70 price target, though RSI levels indicate potential overbought conditions near-term.
The outlook for PAGS is positive given its undervalued metrics and profitability, but risks include macroeconomic pressures in Brazil and elevated credit losses. Institutional interest remains strong, with recent buys from Bank of America. The stock presents a value opportunity with dividend income, though investors should monitor earnings consistency and interest rate impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
